They also used it to discover that SARS-CoV-2 seroconversion status correlates with certain pathophysiological states , such that it could be used as a biosignature to stratify patients for intervention and even inform analyses of clinical trial results ( 2 ).
Perhaps more important , though , is the service that the database can offer other research groups far beyond the Anschutz Campus – groups that can strengthen the database by adding their own work and data to it . All comers are welcome , says Dr . Hsieh . And they seem to be coming : between launch in November 2020 and June of 2021 , the dashboard saw more than 800 unique users from 36 countries around the world . ••
1 . Sullivan KD , Galbraith MD , Kinning KT , Bartsch K , Levinsky N , Araya P , Smith KP , Granrath RE , Shaw JR , Baxter R , Jordan KR , Russell S , Dzieciatkowska M , Reisz JA , Gamboni F , Cendali F , Ghosh T , Monte AA , Bennett TD , Miller MG , Hsieh EWY , D ’ Alessandro A , Hansen KC , Espinosa JM . The COVIDome Explorer Researcher Portal . medRxiv [ Preprint ]. 2021 Mar 8:2021.03.04.21252945 .
2 . Galbraith MD , Kinning KT , Sullivan KD , Baxter R , Araya P , Jordan KR , Russell S , Smith KP , Granrath RE , Shaw JR , Dzieciatkowska M , Ghosh T , Monte AA , D ’ Alessandro A , Hansen KC , Benett TD , Hsieh EW , Espinosa JM . Seroconversion stages COVID19 into distinct pathophysiological states . Elife . 2021 Mar 16 ; 10 : e65508 .
ELENA HSIEH , MD
Pediatric immunologist , Children ’ s Hospital Colorado
Assistant Professor , Allergy & Immunology , Immunology & Microbiology , Pediatrics University of Colorado School of Medicine
endly research it easy to do these ses to answer a questions .”